Graviti Pharmaceuticals
Mini-tablet capsule

Glimigrav MT

Glimepiride + Metformin

1/500 mg2/500 mg2/1000 mg
Glimigrav MT mini-tablet capsule — Glimepiride + Metformin
Indications

Type 2 diabetes where sulfonylurea plus biguanide combination therapy is indicated.

Composition

Each capsule contains mini-tablets of Glimepiride IP and Metformin Hydrochloride IP.

How we make it

Mini-tablet technology: each API compressed separately, then filled — no blend interaction, exact ratios.

This information is intended for healthcare professionals and trade partners. The brand name applies to Graviti's own branded generics range in India; in other markets the same formulation is supplied as a generic under our filings or a partner label. Prescribing information, registration status and pack availability vary by market. Medicines should be used only under qualified medical supervision.

Graviti line producing Glimigrav MT

Glimigrav MT — made to the same standard as every Graviti batch.